Pharma Block Sciences: Announcement on Share Pledges and Pledge Releases by Major Shareholders and Controlling Shareholders.
Pharma Block Sciences: Announcement on adjusting the grant price of 2022 restricted stock incentive plan.
Pharma Block Sciences: Announcement on Invalidating Some Restricted Stocks of the Restricted Stock Incentive Plan for 2022
Pharma Block Sciences: Legal Opinion of Junlan Law Firm Shanghai regarding the adjustment and cancellation of Pharma Block Sciences' 2022 Restricted Stock Incentive Plan.
Pharma Block Sciences: Announcement of Annual Equity Distribution Implementation in 2023
Pharma Block Sciences: Announcement on the completion of the repurchase of the company's shares and changes in shares
Pharma Block Sciences: Announcement on the progress of the repurchase of company shares
Pharma Block Sciences: Announcement on partial share pledges by controlling shareholders and actual controllers
Yakushi Technology: Announcement on the 2023 Profit Distribution Plan
Yakushi Technology: Announcement on the progress of the repurchase of the company's shares
Yakushi Technology: Announcement on the progress of the repurchase of the company's shares
Yakushi Technology: Notice on Supplemental Pledges of Some Shares of Controlling Shareholders and Actual Controllers
Yakushi Technology: Notice on Supplemental Pledges of Some Shares of Controlling Shareholders and Actual Controllers
Yakushi Technology: Announcement on the progress of the repurchase of the company\'s shares
Yakushi Technology: Announcement on the progress of the repurchase of the company\'s shares
Yakushi Technology: Announcement on the progress of the repurchase of the company\'s shares
Yakushi Technology: Announcement on the initial repurchase of the company\'s shares
Pharmaceutical Stone Technology: Announcement on the pledge and cancellation of the pledge of some shares of the controlling shareholder and actual controller
Yakushi Technology: Announcement on the progress of the repurchase of shares
Yakushi Technology: Announcement on the shareholding situation of the top ten shareholders in share repurchase matters and the top ten shareholders with unlimited sales conditions
No Data